• Nenhum resultado encontrado

[PDF] Top 20 Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease

Has 10000 "Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease" found on our website. Below are the top 20 most common "Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease".

Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease

Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease

... In the chronic phase, the number of parasites killed by the immune response should be roughly similar to the number of new parasites arising by ...mechanism ... See full document

8

Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease

Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease

... model of acute and chronic T. cruzi in- fections, BZ treatment resulted in the emergence of ...T. cruzi-specific central memory T-cells (Bustamante et ...in the total numbers ... See full document

8

Trypanosoma cruzi mucins: potential functions of a complex structure

Trypanosoma cruzi mucins: potential functions of a complex structure

... protozoan Trypanosoma cruzi, the etiologi- cal agent of Chagas disease (Chagas 1909), dis- plays on its surface various glycoconjugates which appear to be involved ... See full document

4

Trypanosoma cruzi is the causative agent of Chagas

Trypanosoma cruzi is the causative agent of Chagas

... Trypanosoma cruzi is the causative agent of Chagas disease, and it is estimated that this disease affects 16-18 million persons in South America, causing around ... See full document

5

Immunodiagnosis of Trypanosoma cruzi (Chagas’ Disease) Infection in Naturally Infected Dogs

Immunodiagnosis of Trypanosoma cruzi (Chagas’ Disease) Infection in Naturally Infected Dogs

... positive by ELISA E200 when those cut-off values were ...absorbance of 0.20 pro- vided the lowest number of discordant samples among techniques; the interval from ...eight of ... See full document

8

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease

... for the marked differences in efficacy for the nitroderivatives in the acute and chronic stages of Chagas disease are not known (Cançado ...indices of cure can be detected ... See full document

7

Rev. Soc. Bras. Med. Trop.  vol.49 número1

Rev. Soc. Bras. Med. Trop. vol.49 número1

... infestation by the kissing bug triatomines and their colonization and infection by Trypanosoma cruzi, the Chagas disease agent, were evaluated in nine ... See full document

11

Integrate Study of a Bolivian Population Infected by Trypanosoma cruzi, the Agent of Chagas Disease

Integrate Study of a Bolivian Population Infected by Trypanosoma cruzi, the Agent of Chagas Disease

... summarized the charac- teristics of patients presenting abnormal ECG tracing (32 ...cases). The other 200 individuals had ECG tracing con- sidered as ...Among the 232 studied individuals, ... See full document

7

Igor Correia de Almeida3

Igor Correia de Almeida3

... definition of a biomarker provided by the World Health Organization is any substance, structure, or process that can be measured in the body, or its products and influence, or predict ... See full document

11

Chagas' disease: an update on immune mechanisms and therapeutic strategies

Chagas' disease: an update on immune mechanisms and therapeutic strategies

... During the chronic phase of Chagasdisease, the majority of indi- viduals show potent cellular and humuoral immune responses [77, ...78]. The relevance ... See full document

12

Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease

Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease

... T. cruzi, individuals un- dergo an acute phase that lasts between two and four ...With the exception of the mucosal edema that may appear at the site of infection (when in ... See full document

11

Junei Kinjo3, Simón Hernández-Ortega

Junei Kinjo3, Simón Hernández-Ortega

... from the tropical rain forests of the American ...in the extracts of these ...from the leaves of C. brasiliense. Mammea A/ AA was obtained from the fruit peels ... See full document

6

Swimming against the current: genetic vaccination against Trypanosoma cruzi infection in mice

Swimming against the current: genetic vaccination against Trypanosoma cruzi infection in mice

... In the past, vaccination studies have failed because researchers have in most cases focused on inducing pro- tective ...eliminate the parasites and that the antigens expressed in the ax- enic ... See full document

7

KEYWORDS benznidazole, Chagas disease, Trypanosoma cruzi

KEYWORDS benznidazole, Chagas disease, Trypanosoma cruzi

... T. cruzi infection has limited efficacy, especially during the chronic phase of the disease, when the parasites are mostly confined to deep tissues in which replication occurs (41, ... See full document

9

Looking for combination of benznidazole and Trypanosoma cruzi- triosephosphate isomerase inhibitors for Chagas disease treatment

Looking for combination of benznidazole and Trypanosoma cruzi- triosephosphate isomerase inhibitors for Chagas disease treatment

... days the percentage of growth inhibition (PGI) was calculated for each mixtures as follows: PGI (%) = {1 - [(Ap - A 0 p)/(Ac - A 0 c)]} × 100, where Ap = A 600 nm of the culture containing ... See full document

8

Rev. Soc. Bras. Med. Trop.  vol.49 número6

Rev. Soc. Bras. Med. Trop. vol.49 número6

... Introduction: The aim of this study was to investigate the prevalence of Chagas disease in patients treated at a Public Oncology Service in the City of Pelotas, ... See full document

4

Nutritional Status Driving Infection by Trypanosoma cruzi: Lessons from Experimental Animals

Nutritional Status Driving Infection by Trypanosoma cruzi: Lessons from Experimental Animals

... cases of congestive cardiomyopathy and other cardiovascular complications, including myocardial ...Regarding the study of the effects of selenium deficiency on the ...T. ... See full document

11

Rev. Soc. Bras. Med. Trop.  vol.36 número1

Rev. Soc. Bras. Med. Trop. vol.36 número1

... for the age, reaching 600 kgmts/min. with an adequate elevation of arterial blood pressure (170/90mmHg and CF of 120 bpm) and no disturbances in the ...During the test, basal ... See full document

5

Update on Chagas Disease in Venezuela – A Review

Update on Chagas Disease in Venezuela – A Review

... analysis of the present data related to the epide- miological situation of Chagas disease in Venezuela, lead us to reach the following conclusions: there has been, during ... See full document

7

Decrease in the prevalence of infection by Trypanosoma cruzi (Chagas' disease) in young men of Argentina

Decrease in the prevalence of infection by Trypanosoma cruzi (Chagas' disease) in young men of Argentina

... These aliquots of sera were sent from the 34 medical examination centers to 30 laboratories distributed around the country, 29 of which had been selected by the referen[r] ... See full document

13

Show all 10000 documents...